Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: Phase 1 results from the multicenter EVOLUTION study
- S. K. Kumar
- , I. Flinn
- , S. J. Noga
- , P. Hari
- , R. Rifkin
- , N. Callander
- , M. Bhandari
- , J. L. Wolf
- , C. Gasparetto
- , A. Krishnan
- , D. Grosman
- , J. Glass
- , E. A. Sahovic
- , H. Shi
- , I. J. Webb
- , P. G. Richardson
- , S. V. Rajkumar
Research output: Contribution to journal › Article › peer-review
71
Link opens in a new tab
Scopus
citations